Dr Tracey Mynott Presents at TRI Science Business Inspiration Series
ASX:ANR) CSO, Dr Tracey Mynott, was recently invited to present at the Translational Research Institute's (TRI) Science Business Inspiration Series. The series was launched with Session 1 "The whole journey: from idea to reality". Through her presentation, Tracey shared her personal journey - translating core research about pineapple roots and piglet gut health - to her current status as CSO of a publicly listed company, which is intent on changing the livestock industry globally. To read more, please visit:
http://www.abnnewswire.net/lnk/713SA081
About Anatara Lifesciences Ltd
Anatara Lifesciences (ASX:ANR) is developing therapeutics for gastrointestinal diseases in production animals and humans. Its lead product Detach(R) is a natural plant based product that aids in the control of diarrhoea and will help address global concerns around the overuse of antibiotics in production animals that is contributing to the rise of so-called "super bugs" that make infectious diseases harder to treat. The Anatara team has a strong track record in biological science as well as building and growing international biotech companies.
|
||
|
Related Companies
Anatara Lifesciences Ltd
ABN Newswire
ANALYTICS: LOGIN HERE
